These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 35750927)

  • 1. Signalling mechanisms and cellular functions of SUMO.
    Vertegaal ACO
    Nat Rev Mol Cell Biol; 2022 Nov; 23(11):715-731. PubMed ID: 35750927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatiotemporal distribution of small ubiquitin-like modifiers during human placental development and in response to oxidative and inflammatory stress.
    Baczyk D; Audette MC; Coyaud E; Raught B; Kingdom JC
    J Physiol; 2018 May; 596(9):1587-1600. PubMed ID: 29468681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxes of Cellular SUMOylation Regulation: A Role of Biomolecular Condensates?
    Cheng X; Yang W; Lin W; Mei F
    Pharmacol Rev; 2023 Sep; 75(5):979-1006. PubMed ID: 37137717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. System-wide Analysis of SUMOylation Dynamics in Response to Replication Stress Reveals Novel Small Ubiquitin-like Modified Target Proteins and Acceptor Lysines Relevant for Genome Stability.
    Xiao Z; Chang JG; Hendriks IA; Sigurðsson JO; Olsen JV; Vertegaal AC
    Mol Cell Proteomics; 2015 May; 14(5):1419-34. PubMed ID: 25755297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive compilation of SUMO proteomics.
    Hendriks IA; Vertegaal AC
    Nat Rev Mol Cell Biol; 2016 Sep; 17(9):581-95. PubMed ID: 27435506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the SUMOylated landscape.
    Eifler K; Vertegaal AC
    FEBS J; 2015 Oct; 282(19):3669-80. PubMed ID: 26185901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMO: From Bench to Bedside.
    Chang HM; Yeh ETH
    Physiol Rev; 2020 Oct; 100(4):1599-1619. PubMed ID: 32666886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
    Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
    J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMOylation and cell signalling.
    Andreou AM; Tavernarakis N
    Biotechnol J; 2009 Dec; 4(12):1740-52. PubMed ID: 19946876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin and SUMO Modifications in
    Drabikowski K
    Curr Issues Mol Biol; 2020; 35():145-158. PubMed ID: 31422938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small ubiquitin-related modifiers in chains.
    Vertegaal AC
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1422-3. PubMed ID: 18031236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of biochemically distinct properties of the small ubiquitin-related modifier (SUMO) conjugation pathway in Plasmodium falciparum.
    Reiter K; Mukhopadhyay D; Zhang H; Boucher LE; Kumar N; Bosch J; Matunis MJ
    J Biol Chem; 2013 Sep; 288(39):27724-36. PubMed ID: 23943616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The post-translational modification, SUMOylation, and cancer (Review).
    Han ZJ; Feng YH; Gu BH; Li YM; Chen H
    Int J Oncol; 2018 Apr; 52(4):1081-1094. PubMed ID: 29484374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of Adenovirus E4-ORF3-Mediated SUMO Modifications.
    Sohn SY; Hearing P
    mBio; 2019 Feb; 10(1):. PubMed ID: 30808699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The strategies for identification and quantification of SUMOylation.
    Zhang Y; Li Y; Tang B; Zhang CY
    Chem Commun (Camb); 2017 Jun; 53(52):6989-6998. PubMed ID: 28589199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
    Coey CT; Fitzgerald ME; Maiti A; Reiter KH; Guzzo CM; Matunis MJ; Drohat AC
    J Biol Chem; 2014 May; 289(22):15810-9. PubMed ID: 24753249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPS-SUMO: a tool for the prediction of sumoylation sites and SUMO-interaction motifs.
    Zhao Q; Xie Y; Zheng Y; Jiang S; Liu W; Mu W; Liu Z; Zhao Y; Xue Y; Ren J
    Nucleic Acids Res; 2014 Jul; 42(Web Server issue):W325-30. PubMed ID: 24880689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.
    González-Prieto R; Cuijpers SA; Kumar R; Hendriks IA; Vertegaal AC
    Cell Cycle; 2015; 14(12):1859-72. PubMed ID: 25895136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights in Post-Translational Modifications: Ubiquitin and SUMO.
    Salas-Lloret D; González-Prieto R
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMO and the DNA damage response.
    Bhachoo JS; Garvin AJ
    Biochem Soc Trans; 2024 Apr; 52(2):773-792. PubMed ID: 38629643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.